Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
NCT00370422
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
Triamcinolone, Bevacizumab
Sponsor
Shahid Beheshti University of Medical Sciences